UNSPSC 51191804: Potassium acetate

This classification denotes an electrolyte replacement agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M911911U02. European Medicines Agency schedules Potassium acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14962MIG. Potassium acetate generally arises in the molecular formula C2H4O2.K. The term POTASSIUM ACETATE is a United States Homeopathic Pharmacopoeia Name designation. Most nations schedule potassium acetate under HS 29152900 and SITC 51371.

As of Q4 2014, POTASSIUM ACETATE remains the US FDA Preferred Term for this commodity. Potassium acetate bears US NLM identifiers UMLS ID C0137984 and NCI Concept Code C47677. SMILES: CC(=O)[O-].[K+].

UNSPSC 51191804 Potassium acetate is a Commodity code that captures chemical supply to state and local water treatment, wastewater handling, and correctional healthcare operations. Recent state and local solicitations under this code show demand for specialized chemical products and related services: water treatment chemicals (sodium bisulfite for municipal pollution control facilities), parenteral nutrition and intravenous solutions for correctional health systems, and valve components and repair services for wastewater treatment infrastructure. Issuing bodies include municipal utilities (water pollution control facilities), state correctional departments, and county public works and purchasing offices. The work spans supply of the chemical commodity itself, delivery logistics with strict time-window requirements (especially in healthcare contexts), technical documentation and compliance certification, and in some cases integrated maintenance and repair services.

Recent activity appears in three distinct procurement streams: the City of Meriden, Connecticut issued an IFB for sodium bisulfite chemical supply to its Water Pollution Control Facility with a due date of July 29, 2026; Broward County, Florida posted an RFI (solicitation BLD6232026F23, due September 29, 2026) seeking qualified suppliers of DeZurik/APCO valves and repair services for wastewater treatment compliance, currently under sole-source designation to Controls Specialties, Inc.; and the Washington State Department of Corrections issued an RFQQ (RFQQK13020, due October 7, 2026) for parenteral products and services including TPN, PPN, and IV solutions across eight facilities across the state, with a pre-bid conference on September 23, 2026, firm pricing for two years, and multiple awards expected (up to three per region). Geographic activity centers on the Northeast (Connecticut), Southeast (Florida), and Pacific Northwest (Washington), with no recent opportunities reported outside these regions. The Washington DOC opportunity emphasizes small business (25%), minority-owned (10%), women-owned (6%), and veteran-owned (5%) participation through state-certified programs and subcontractor inclusion plans.